⌘K

Home/Filings/4/0001144204-18-037213

4//SEC Filing

Zhou Quan 4

Accession 0001144204-18-037213

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 3:38 PM ET

Size

5.4 KB

Accession

0001144204-18-037213

Insider Transaction Report

Form 4

Period: 2018-06-29

CASI Pharmaceuticals, Inc.CASI

Director10% Owner

Transactions

Award
Stock Options (Right to Buy)
2018-06-29+50,000→ 50,000 total
Exercise: $8.23Exp: 2028-06-29→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of one year.

Documents

1 file

4
tv497980_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001491503

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 3:38 PM ET
Size: 5.4 KB

View on SEC.gov